Elixinol Wellness Ltd
EXL
Company Profile
Business description
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries. It derives maximum revenue from Australia.
Contact
51 - 53 Riversdale Road
NewtownVIC3220
AUST: +61 1300384692
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
Stocks News & Analysis
stocks
Wide moat ASX share beats earnings guidance
Wide moat share continues to grow despite a challenging residential construction market.
stocks
Cheap with attractive yield: Fair Value lifted for retail REIT after earnings
Management expects both earnings and distributions to increase next year.
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,438.80 | 13.00 | 0.14% |
| CAC 40 | 8,726.03 | 11.10 | 0.13% |
| DAX 40 | 26,323.88 | 4.43 | 0.02% |
| Dow JONES (US) | 53,975.98 | 60.95 | -0.11% |
| FTSE 100 | 10,862.50 | 38.59 | -0.35% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,605.36 | 85.26 | -0.32% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,829.53 | 58.71 | -0.42% |
| S&P 500 | 7,753.11 | 4.53 | -0.06% |
| S&P/ASX 200 | 9,247.80 | 11.00 | 0.12% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |